相关实验视频

Updated: Jun 28, 2025

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

调节器针对Mycobacterium结核病中的蛋白质-蛋白质相互作用

Guofeng Luo¹, Tianqi Ming², Luchuan Yang³

¹School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

Microbiological research

|April 18, 2024

概括

由于现有的治疗限制,开发新的结核病 (TB) 药物至关重要. 在Mycobacterium tuberculosis中准蛋白与蛋白相互作用 (PPI) 为开发新型抗结核药物提供了一个有前途的战略.

科学领域:

微生物学微生物学
药物发现药物发现药物发现
生物信息学是一种生物信息学.

背景情况:

结核病 (TB) 仍然是一个重大的全球卫生挑战,由结核菌菌引起.
目前的抗结核病药物面临着包括副作用和耐药性在内的局限性,需要新的治疗策略.
蛋白与蛋白相互作用 (PPI) 是开发新抗结核病药物的有希望的目标类.

研究的目的:

探索针对Mycobacterium tuberculosis的PPI针对新药开发的潜力.
提供对抗结核病PPI调节器的研究进展和监管机制的概述.
确定潜在的药物点,并讨论PPI调节器在结核病治疗中的未来前景.

主要方法:

使用计算和生物信息学工具,构建一个针对Mycobacterium tuberculosis的全面PPI网络.
深入分析已识别的PPI的结构生物学.
审查关于PPI调节器及其监管机制的现有研究.

主要成果:

建立了针对Mycobacterium tuberculosis的详细的PPI网络.
该网络为PPI的结构生物学提供了洞察力,有助于设计有针对性的调节器.
确定了开发抗结核病药物的潜在目标.

结论:

针对Mycobacterium tuberculosis中的PPI是开发新型抗结核药物的可行和重要的战略.
对PPI调节器的进一步研究对克服耐药性和提高结核病治疗疗效具有重大前景.
开发的PPI网络是未来针对结核病的药物发现工作的宝贵资源.

关键词:

结核病菌菌菌的结核病菌的结核病菌.细胞壁的细胞壁.遗传学遗传学遗传学遗传学是一个有关信息信息信息信息信息信息.模块化器是一个模块化器.蛋白质与蛋白质的相互作用毒性因素是毒性的因素.

更多相关视频

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis

Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis

Published on: March 28, 2025

相关概念视频

Types of RNA

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...

Cooperative Allosteric Transitions

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...

Covalently Linked Protein Regulators

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....

RNA Polymerase II Accessory Proteins

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...